Kevin Schey

Vanderbilt researchers, in collaboration with investigators from the University of Alabama at Birmingham, the Delft University of Technology, University Hospital Bonn, and Molecular Horizon have developed new protocols to study which molecular pathways might be important in the aging retina and what might cause the formation of deposits in the eye that confer high risk for age-related macular degeneration. Read More

Learn about current treatments for cataracts, age-related macular degeneration and glaucoma and how new technologies are moving these discoveries forward at the next Lab-to-Table Conversation on June 27. Read More

Vanderbilt and Bruker Daltonics are collaborating to establish a Mass Spectrometry Center of Excellence with four state-of-the-art mass spectrometers to advance biomedical research and discovery. Read More

By determining how proteins in different areas of the eye’s lens change over time, Vanderbilt researchers have learned more about how they could contribute to the mysterious progression of cataracts—a clouding of the lens that affects more than 65 million people worldwide each year.   Read More

Vanderbilt contributes molecular imaging data of kidney to the Human BioMolecular Atlas Program, a consortium of 18 diverse collaborative research teams across the United States and Europe. Read More

Five Vanderbilt University faculty members have been elected new fellows of the American Association for the Advancement of Science, the world’s largest general scientific society.  Read More

Researchers identify protein partners that may keep the lens of the eye transparent – and free from cataracts. Read More